Literature DB >> 4224601

"Collagen disease" due to carbamazepine (Tegretol).

J R Simpson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 4224601      PMCID： PMC1944890          DOI： 10.1136/bmj.2.5527.1434

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  9 in total

1.  Carbamazepine induced vasculitis.

Authors:  N Harats; M Shalit
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-09       Impact factor: 10.154

Review 2.  The side-effects of carbamazepine.

Authors:  J J Gayford; T H Redpath
Journal:  Proc R Soc Med       Date:  1969-06

3.  Carbamazepine induced systemic lupus erythematosus: case report.

Authors:  D E Bateman
Journal:  Br Med J (Clin Res Ed)       Date:  1985-09-07

Review 4.  The risk-benefit ratio of anticonvulsant drugs.

Authors:  M J Eadie
Journal:  Med Toxicol Adverse Drug Exp       Date:  1987 Sep-Oct

Review 5.  Antiepileptic drug toxicity: definition and mechanism of action.

Authors:  E Beghi; R Di Mascio
Journal:  Ital J Neurol Sci       Date:  1986-04

Review 6.  Systemic lupus erythematosus (SLE)-like syndromes associated with carbamazepine therapy.

Authors:  K K Jain
Journal:  Drug Saf       Date:  1991 Sep-Oct       Impact factor: 5.606

7.  Bullous skin eruption associated with carbamazepine overdosage.

Authors:  D J Godden; J L McPhie
Journal:  Postgrad Med J       Date:  1983-05       Impact factor: 2.401

8.  The Mechanistic Differences in HLA-Associated Carbamazepine Hypersensitivity.

Authors:  Gwendolin S Simper; Lareen S Gräser; Alexander A Celik; Joachim Kuhn; Heike Kunze-Schumacher; Gia-Gia T Hò; Rainer Blasczyk; Andreas Pich; Christina Bade-Doeding
Journal:  Pharmaceutics       Date:  2019-10-15       Impact factor: 6.321

9.  Carbamazepine-Mediated Adverse Drug Reactions: CBZ-10,11-epoxide but Not Carbamazepine Induces the Alteration of Peptides Presented by HLA-B∗15:02.

Authors:  Gwendolin S Simper; Gia-Gia T Hò; Alexander A Celik; Trevor Huyton; Joachim Kuhn; Heike Kunze-Schumacher; Rainer Blasczyk; Christina Bade-Döding
Journal:  J Immunol Res       Date:  2018-09-13       Impact factor: 4.818
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.